Ambu ASAMBBY 84 Days Payable is 77.18 as of Mar. 2026, which is 9% above its 10-year median of 70.86. GuruFocus rates AMBBY with a GF Score™ of 84/100 and a GF Value™ of $19.84 (Significantly Undervalued). Among 796 Medical Devices & Instruments companies, Ambu AS ranks better than 56.53% on this metric.
Ambu AS's average Accounts Payable for the
three
months ended in Mar. 2026 was $81.8 Mil. Ambu AS's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $96.7 Mil.
Hence, Ambu AS's Days Payable for the
three
months ended in Mar. 2026 was 77.18.
The historical rank and industry rank for Ambu AS's Days Payable or its related term are showing as below:
AMBBY'
s Days Payable Range Over the Past 10 Years
Min: 41.63 Med: 70.86 Max: 93.08
Current: 79.6
During the past 13 years, Ambu AS's highest Days Payable was 93.08. The lowest was 41.63. And the median was 70.86.
AMBBY's Days Payable is ranked better than 56.53% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 68.14
vs AMBBY: 79.60
Ambu AS's Days Payable
declined
from Mar. 2025 (80.22) to Mar. 2026 (77.18).
It may suggest that Ambu ASaccelerated paying its suppliers.
Ambu AS Days Payable Related Terms
Ambu AS Days Payable Historical Data
* Premium members only.
The historical data trend for Ambu AS's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Ambu AS's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ambu AS Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ambu AS's Days Payable distribution charts can be found below:
* The bar in red indicates where Ambu AS's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Ambu AS's Days Payable for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ambu AS (AMBBY) has a Days Payable of 77.18 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ambu AS and its competitors. This is near median its historical median of 70.86. Over the past decade, Ambu AS's Days Payable has ranged from 41.63 to 93.08. According to the industry distribution chart, Ambu AS ranks #346 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 43.5%.
Is Ambu AS's Days Payable too high?
Ambu AS's current Days Payable of 77.18 is near median its 10-year median of 70.86. Over the past 10 years, this metric has ranged from a low of 41.63 to a high of 93.08. The Medical Devices & Instruments industry median Days Payable is 68.14. Ambu AS's value of 77.18 is 13.3% above this industry median. Based on the distribution chart, Ambu AS ranks #346 out of 796 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Ambu AS has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ambu AS's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ambu AS ranks #346 out of 796 companies for Days Payable. This puts Ambu AS in the upper half of its industry. The industry median Days Payable is 68.14. Ambu AS's value of 77.18 is 13.3% above this benchmark. Historically, Ambu AS's own Days Payable has ranged from 41.63 to 93.08 over the past decade. While the company's 10-year median is 70.86 vs. the industry median of 68.14, Ambu AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.14, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ambu AS's current Days Payable of 77.18 is 13.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ambu AS and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ambu AS's current Days Payable is 77.18, which is near median its own 10-year median of 70.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambu AS stock overvalued right now?
Based on GuruFocus' analysis, Ambu AS (AMBBY) is currently considered Significantly Undervalued. The stock's GF Value™ is $19.84, compared to a current price of $9.43 — trading 52.5% below its estimated fair value. The current Days Payable is 77.18, which is near median its 10-year median of 70.86 and 13.3% above the Medical Devices & Instruments industry median of 68.14. Ambu AS's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Ambu AS (AMBBY), the current Days Payable is 77.18 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ambu AS (AMBBY) Overvalued in 2026?
Based on GuruFocus' analysis, Ambu AS stock appears to be undervalued.
The current stock price of $9.43 is trading 52.5% below its estimated GF Value™ of $19.84.
GuruFocus considers Ambu AS to be Significantly Undervalued.
Key valuation signals for AMBBY:
Days Payable: 77.18 (near median its 10-year median of 70.86)
GF Value™: $19.84 vs. price of $9.43 (52.5% below fair value)
Industry Position: 13.3% above the Medical Devices & Instruments median (#346 of 796)
No single metric tells the full story. See the AMBBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
84GF Score
Get the complete analysis for AMBBY
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMBBY has been successfully added to your 
